PMCN-M Stock Overview
Engages in the multiplication, cultivation, production, and sale of cannabis for medical purposes. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Pharmocann Global Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪1.85 |
| 52 Week High | ₪4.00 |
| 52 Week Low | ₪0.51 |
| Beta | -0.18 |
| 1 Month Change | 56.38% |
| 3 Month Change | 8.82% |
| 1 Year Change | 32.05% |
| 3 Year Change | -96.99% |
| 5 Year Change | -99.32% |
| Change since IPO | -99.40% |
Recent News & Updates
Recent updates
The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence
Mar 30
Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?
Feb 04Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 31
The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come
Nov 26Shareholder Returns
| PMCN-M | IL Pharmaceuticals | IL Market | |
|---|---|---|---|
| 7D | -0.6% | -1.4% | -1.5% |
| 1Y | 32.0% | -3.4% | 22.2% |
Return vs Industry: PMCN-M exceeded the IL Pharmaceuticals industry which returned -3.4% over the past year.
Return vs Market: PMCN-M exceeded the IL Market which returned 22.2% over the past year.
Price Volatility
| PMCN-M volatility | |
|---|---|
| PMCN-M Average Weekly Movement | 15.9% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in IL Market | 8.3% |
| 10% least volatile stocks in IL Market | 3.0% |
Stable Share Price: PMCN-M's share price has been volatile over the past 3 months compared to the IL market.
Volatility Over Time: Insufficient data to determine PMCN-M's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 14 | Meir Shimon | www.pharmacann.co.il |
Pharmocann Global Ltd engages in the multiplication, cultivation, production, and sale of cannabis for medical purposes. It provides cannabis to treat patients with depression and Alzheimer's. The company produces tons of processed cannabis.
Pharmocann Global Ltd Fundamentals Summary
| PMCN-M fundamental statistics | |
|---|---|
| Market cap | ₪5.94m |
| Earnings (TTM) | -₪10.23m |
| Revenue (TTM) | ₪13.45m |
0.4x
P/S Ratio-0.6x
P/E RatioIs PMCN-M overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PMCN-M income statement (TTM) | |
|---|---|
| Revenue | ₪13.45m |
| Cost of Revenue | ₪15.53m |
| Gross Profit | -₪2.08m |
| Other Expenses | ₪8.15m |
| Earnings | -₪10.23m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.19 |
| Gross Margin | -15.46% |
| Net Profit Margin | -76.06% |
| Debt/Equity Ratio | 0% |
How did PMCN-M perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/29 13:11 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Pharmocann Global Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|